Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 777

Similar articles for PubMed (Select 19545988)

1.

Docosahexaenoic acid (DHA) and cardiovascular disease risk factors.

Holub BJ.

Prostaglandins Leukot Essent Fatty Acids. 2009 Aug-Sep;81(2-3):199-204. doi: 10.1016/j.plefa.2009.05.016. Epub 2009 Jul 9. Review.

PMID:
19545988
2.

n-3 fatty acids and cardiovascular disease.

Breslow JL.

Am J Clin Nutr. 2006 Jun;83(6 Suppl):1477S-1482S. Review.

3.

Omega-3 fatty acids from fish oils and cardiovascular disease.

Holub DJ, Holub BJ.

Mol Cell Biochem. 2004 Aug;263(1-2):217-25. Review.

PMID:
15524182
4.

Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.

Rupp H, Wagner D, Rupp T, Schulte LM, Maisch B.

Herz. 2004 Nov;29(7):673-85. Review. Erratum in: Herz. 2004 Dec;29(8):805.

PMID:
15580322
7.

Cardiovascular disease prevention and treatment.

von Schacky C.

Prostaglandins Leukot Essent Fatty Acids. 2009 Aug-Sep;81(2-3):193-8. doi: 10.1016/j.plefa.2009.05.009. Epub 2009 Jun 10. Review.

PMID:
19520557
8.

Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.

Pauwels EK, Kostkiewicz M.

Drug News Perspect. 2008 Dec;21(10):552-61. doi: 10.1358/dnp.2008.21.10.1314058. Review.

PMID:
19221636
9.

Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.

McKenney JM, Sica D.

Pharmacotherapy. 2007 May;27(5):715-28. Review.

PMID:
17461707
10.

Omega-3 fatty acids and cardiovascular disease.

von Schacky C.

Curr Opin Clin Nutr Metab Care. 2007 Mar;10(2):129-35. Review.

PMID:
17284999
11.

Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.

Marik PE, Varon J.

Clin Cardiol. 2009 Jul;32(7):365-72. doi: 10.1002/clc.20604. Review.

PMID:
19609891
12.

n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study.

Lemaitre RN, King IB, Mozaffarian D, Kuller LH, Tracy RP, Siscovick DS.

Am J Clin Nutr. 2003 Feb;77(2):319-25.

13.

Effect of supplementation with dietary seal oil on selected cardiovascular risk factors and hemostatic variables in healthy male subjects.

Conquer JA, Cheryk LA, Chan E, Gentry PA, Holub BJ.

Thromb Res. 1999 Nov 1;96(3):239-50.

PMID:
10588467
14.

Clinical overview of algal-docosahexaenoic acid: effects on triglyceride levels and other cardiovascular risk factors.

Ryan AS, Keske MA, Hoffman JP, Nelson EB.

Am J Ther. 2009 Mar-Apr;16(2):183-92. doi: 10.1097/MJT.0b013e31817fe2be. Review.

PMID:
19145206
15.

Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects.

Buckley R, Shewring B, Turner R, Yaqoob P, Minihane AM.

Br J Nutr. 2004 Sep;92(3):477-83.

PMID:
15469651
17.

Relations between n-3 fatty acid status and cardiovascular disease risk factors among Quebecers.

Dewailly E E, Blanchet C, Gingras S, Lemieux S, Sauvé L, Bergeron J, Holub BJ.

Am J Clin Nutr. 2001 Nov;74(5):603-11.

18.

Omega-3 polyunsaturated fatty acids and cardiovascular diseases.

Lavie CJ, Milani RV, Mehra MR, Ventura HO.

J Am Coll Cardiol. 2009 Aug 11;54(7):585-94. doi: 10.1016/j.jacc.2009.02.084. Review.

19.

Dietary reference intakes for DHA and EPA.

Kris-Etherton PM, Grieger JA, Etherton TD.

Prostaglandins Leukot Essent Fatty Acids. 2009 Aug-Sep;81(2-3):99-104. doi: 10.1016/j.plefa.2009.05.011. Epub 2009 Jun 13.

PMID:
19525100
20.

Microdetermination of fatty acids by gas chromatography and cardiovascular risk stratification by the "EPA+DHA level".

Rupp H, Rupp TP, Wagner D, Alter P, Maisch B.

Herz. 2006 Dec;31 Suppl 3:30-49. Review.

PMID:
17575804
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk